- Home
- PTGX vs ALVO Comparison
PTGX vs ALVO Comparison
Compare PTGX & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- ALVO
- Stock Information
- Founded
- PTGX 2006
- ALVO 2013
- Country
- PTGX United States
- ALVO Luxembourg
- Employees
- PTGX N/A
- ALVO N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- PTGX Health Care
- ALVO Health Care
- Exchange
- PTGX Nasdaq
- ALVO Nasdaq
- Market Cap
- PTGX 2.9B
- ALVO 2.5B
- IPO Year
- PTGX 2016
- ALVO N/A
- Fundamental
- Price
- PTGX $51.39
- ALVO $9.17
- Analyst Decision
- PTGX Strong Buy
- ALVO Buy
- Analyst Count
- PTGX 9
- ALVO 1
- Target Price
- PTGX $67.11
- ALVO $18.00
- AVG Volume (30 Days)
- PTGX 1.0M
- ALVO 199.0K
- Earning Date
- PTGX 08-05-2025
- ALVO 08-14-2025
- Dividend Yield
- PTGX N/A
- ALVO N/A
- EPS Growth
- PTGX N/A
- ALVO N/A
- EPS
- PTGX 0.86
- ALVO 0.34
- Revenue
- PTGX $207,801,000.00
- ALVO $587,890,000.00
- Revenue This Year
- PTGX N/A
- ALVO $35.07
- Revenue Next Year
- PTGX $47.15
- ALVO $44.61
- P/E Ratio
- PTGX $64.57
- ALVO $26.91
- Revenue Growth
- PTGX N/A
- ALVO 413.92
- 52 Week Low
- PTGX $32.50
- ALVO $7.35
- 52 Week High
- PTGX $60.60
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- PTGX 61.93
- ALVO 39.79
- Support Level
- PTGX $52.16
- ALVO $9.06
- Resistance Level
- PTGX $57.24
- ALVO $9.51
- Average True Range (ATR)
- PTGX 1.71
- ALVO 0.30
- MACD
- PTGX -0.25
- ALVO -0.09
- Stochastic Oscillator
- PTGX 55.96
- ALVO 21.07
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.